Natriuretic Peptides as a Novel Target in Resistant Hypertension View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2015-03-10

AUTHORS

Pratik Patel, Horng H. Chen

ABSTRACT

Resistant hypertension is defined as blood pressure not under goal despite being on at least three antihypertensives. Resistant hypertension is associated with significant cardiovascular morbidity and mortality. Currently, the mainstay for the treatment of resistant hypertension is lifestyle modification and antihypertensive drugs. Natriuretic peptides play an important role in regulating cardiovascular hemodynamics and sodium and fluid homeostasis including blood pressure control. They hold a promising potential for treatment of resistant hypertension. More... »

PAGES

18

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s11906-014-0530-0

DOI

http://dx.doi.org/10.1007/s11906-014-0530-0

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1006134265

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/25754322


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1102", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Cardiorespiratory Medicine and Haematology", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antihypertensive Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Homeostasis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hypertension", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Natriuretic Peptides", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prognosis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Risk Factors", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA", 
          "id": "http://www.grid.ac/institutes/grid.66875.3a", 
          "name": [
            "Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Patel", 
        "givenName": "Pratik", 
        "id": "sg:person.0664020231.70", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0664020231.70"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Cardiovascular Diseases, Mayo Clinic, Rochester, MN200 First Street SW, 55905, Rochester, MN, USA", 
          "id": "http://www.grid.ac/institutes/grid.66875.3a", 
          "name": [
            "Division of Cardiovascular Diseases, Mayo Clinic, Rochester, MN200 First Street SW, 55905, Rochester, MN, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Chen", 
        "givenName": "Horng H.", 
        "id": "sg:person.01024326700.50", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01024326700.50"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s00109-010-0641-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045002962", 
          "https://doi.org/10.1007/s00109-010-0641-2"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/ng.328", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035621233", 
          "https://doi.org/10.1038/ng.328"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/jhh.2012.29", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026351078", 
          "https://doi.org/10.1038/jhh.2012.29"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s11906-011-0244-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012051007", 
          "https://doi.org/10.1007/s11906-011-0244-5"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2015-03-10", 
    "datePublishedReg": "2015-03-10", 
    "description": "Resistant hypertension is defined as blood pressure not under goal despite being on at least three antihypertensives. Resistant hypertension is associated with significant cardiovascular morbidity and mortality. Currently, the mainstay for the treatment of resistant hypertension is lifestyle modification and antihypertensive drugs. Natriuretic peptides play an important role in regulating cardiovascular hemodynamics and sodium and fluid homeostasis including blood pressure control. They hold a promising potential for treatment of resistant hypertension.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s11906-014-0530-0", 
    "inLanguage": "en", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1021183", 
        "issn": [
          "1522-6417", 
          "1534-3111"
        ], 
        "name": "Current Hypertension Reports", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "3", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "17"
      }
    ], 
    "keywords": [
      "resistant hypertension", 
      "natriuretic peptide", 
      "significant cardiovascular morbidity", 
      "blood pressure control", 
      "cardiovascular morbidity", 
      "lifestyle modification", 
      "blood pressure", 
      "antihypertensive drugs", 
      "cardiovascular hemodynamics", 
      "hypertension", 
      "pressure control", 
      "fluid homeostasis", 
      "novel target", 
      "treatment", 
      "morbidity", 
      "antihypertensives", 
      "hemodynamics", 
      "mainstay", 
      "mortality", 
      "peptides", 
      "important role", 
      "drugs", 
      "homeostasis", 
      "sodium", 
      "control", 
      "target", 
      "role", 
      "pressure", 
      "potential", 
      "promising potential", 
      "goal", 
      "modification"
    ], 
    "name": "Natriuretic Peptides as a Novel Target in Resistant Hypertension", 
    "pagination": "18", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1006134265"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s11906-014-0530-0"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "25754322"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s11906-014-0530-0", 
      "https://app.dimensions.ai/details/publication/pub.1006134265"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-01-01T18:37", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220101/entities/gbq_results/article/article_665.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s11906-014-0530-0"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s11906-014-0530-0'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s11906-014-0530-0'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s11906-014-0530-0'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s11906-014-0530-0'


 

This table displays all metadata directly associated to this object as RDF triples.

147 TRIPLES      22 PREDICATES      69 URIs      57 LITERALS      14 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s11906-014-0530-0 schema:about N1b420a43486b40a8856b80ebbd8c18fe
2 N3d59af07cf72434b93cf30740f1a8f75
3 N4ad65f6972f640daa4c94419627c5081
4 N54a8b0134d8a4e6393d156547076b525
5 Na10a87d280fa48b7827003dd391106c5
6 Nde983fd0a471448f93f211500aa444af
7 Neec6144334684e2187b603442a66d700
8 anzsrc-for:11
9 anzsrc-for:1102
10 schema:author N0402ff7e6bb147d38419418395c2867b
11 schema:citation sg:pub.10.1007/s00109-010-0641-2
12 sg:pub.10.1007/s11906-011-0244-5
13 sg:pub.10.1038/jhh.2012.29
14 sg:pub.10.1038/ng.328
15 schema:datePublished 2015-03-10
16 schema:datePublishedReg 2015-03-10
17 schema:description Resistant hypertension is defined as blood pressure not under goal despite being on at least three antihypertensives. Resistant hypertension is associated with significant cardiovascular morbidity and mortality. Currently, the mainstay for the treatment of resistant hypertension is lifestyle modification and antihypertensive drugs. Natriuretic peptides play an important role in regulating cardiovascular hemodynamics and sodium and fluid homeostasis including blood pressure control. They hold a promising potential for treatment of resistant hypertension.
18 schema:genre article
19 schema:inLanguage en
20 schema:isAccessibleForFree false
21 schema:isPartOf Na6b26585969c4a3887a0f74e7df1e2d9
22 Nbbac08f3ef264d368dc871df9b5f3539
23 sg:journal.1021183
24 schema:keywords antihypertensive drugs
25 antihypertensives
26 blood pressure
27 blood pressure control
28 cardiovascular hemodynamics
29 cardiovascular morbidity
30 control
31 drugs
32 fluid homeostasis
33 goal
34 hemodynamics
35 homeostasis
36 hypertension
37 important role
38 lifestyle modification
39 mainstay
40 modification
41 morbidity
42 mortality
43 natriuretic peptide
44 novel target
45 peptides
46 potential
47 pressure
48 pressure control
49 promising potential
50 resistant hypertension
51 role
52 significant cardiovascular morbidity
53 sodium
54 target
55 treatment
56 schema:name Natriuretic Peptides as a Novel Target in Resistant Hypertension
57 schema:pagination 18
58 schema:productId N172b1cb8e32f4129a8ca9941cbdbdd20
59 Nd551680734ec460a9e25a0030a66ad9c
60 Ndb2b6bf92c47488197ab66f68c0a8722
61 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006134265
62 https://doi.org/10.1007/s11906-014-0530-0
63 schema:sdDatePublished 2022-01-01T18:37
64 schema:sdLicense https://scigraph.springernature.com/explorer/license/
65 schema:sdPublisher N345a18a13de64510a2640a17f41bde4e
66 schema:url https://doi.org/10.1007/s11906-014-0530-0
67 sgo:license sg:explorer/license/
68 sgo:sdDataset articles
69 rdf:type schema:ScholarlyArticle
70 N0402ff7e6bb147d38419418395c2867b rdf:first sg:person.0664020231.70
71 rdf:rest N74782d00111c4ce0af15dcafd218cc11
72 N172b1cb8e32f4129a8ca9941cbdbdd20 schema:name dimensions_id
73 schema:value pub.1006134265
74 rdf:type schema:PropertyValue
75 N1b420a43486b40a8856b80ebbd8c18fe schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
76 schema:name Risk Factors
77 rdf:type schema:DefinedTerm
78 N345a18a13de64510a2640a17f41bde4e schema:name Springer Nature - SN SciGraph project
79 rdf:type schema:Organization
80 N3d59af07cf72434b93cf30740f1a8f75 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
81 schema:name Homeostasis
82 rdf:type schema:DefinedTerm
83 N4ad65f6972f640daa4c94419627c5081 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
84 schema:name Hypertension
85 rdf:type schema:DefinedTerm
86 N54a8b0134d8a4e6393d156547076b525 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
87 schema:name Natriuretic Peptides
88 rdf:type schema:DefinedTerm
89 N74782d00111c4ce0af15dcafd218cc11 rdf:first sg:person.01024326700.50
90 rdf:rest rdf:nil
91 Na10a87d280fa48b7827003dd391106c5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
92 schema:name Prognosis
93 rdf:type schema:DefinedTerm
94 Na6b26585969c4a3887a0f74e7df1e2d9 schema:issueNumber 3
95 rdf:type schema:PublicationIssue
96 Nbbac08f3ef264d368dc871df9b5f3539 schema:volumeNumber 17
97 rdf:type schema:PublicationVolume
98 Nd551680734ec460a9e25a0030a66ad9c schema:name pubmed_id
99 schema:value 25754322
100 rdf:type schema:PropertyValue
101 Ndb2b6bf92c47488197ab66f68c0a8722 schema:name doi
102 schema:value 10.1007/s11906-014-0530-0
103 rdf:type schema:PropertyValue
104 Nde983fd0a471448f93f211500aa444af schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
105 schema:name Humans
106 rdf:type schema:DefinedTerm
107 Neec6144334684e2187b603442a66d700 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
108 schema:name Antihypertensive Agents
109 rdf:type schema:DefinedTerm
110 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
111 schema:name Medical and Health Sciences
112 rdf:type schema:DefinedTerm
113 anzsrc-for:1102 schema:inDefinedTermSet anzsrc-for:
114 schema:name Cardiorespiratory Medicine and Haematology
115 rdf:type schema:DefinedTerm
116 sg:journal.1021183 schema:issn 1522-6417
117 1534-3111
118 schema:name Current Hypertension Reports
119 schema:publisher Springer Nature
120 rdf:type schema:Periodical
121 sg:person.01024326700.50 schema:affiliation grid-institutes:grid.66875.3a
122 schema:familyName Chen
123 schema:givenName Horng H.
124 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01024326700.50
125 rdf:type schema:Person
126 sg:person.0664020231.70 schema:affiliation grid-institutes:grid.66875.3a
127 schema:familyName Patel
128 schema:givenName Pratik
129 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0664020231.70
130 rdf:type schema:Person
131 sg:pub.10.1007/s00109-010-0641-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045002962
132 https://doi.org/10.1007/s00109-010-0641-2
133 rdf:type schema:CreativeWork
134 sg:pub.10.1007/s11906-011-0244-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012051007
135 https://doi.org/10.1007/s11906-011-0244-5
136 rdf:type schema:CreativeWork
137 sg:pub.10.1038/jhh.2012.29 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026351078
138 https://doi.org/10.1038/jhh.2012.29
139 rdf:type schema:CreativeWork
140 sg:pub.10.1038/ng.328 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035621233
141 https://doi.org/10.1038/ng.328
142 rdf:type schema:CreativeWork
143 grid-institutes:grid.66875.3a schema:alternateName Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA
144 Division of Cardiovascular Diseases, Mayo Clinic, Rochester, MN200 First Street SW, 55905, Rochester, MN, USA
145 schema:name Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA
146 Division of Cardiovascular Diseases, Mayo Clinic, Rochester, MN200 First Street SW, 55905, Rochester, MN, USA
147 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...